دورية أكاديمية
أعرض في EDS

Progress and Discussion of Perioperative Targeted Therapy in Patients with EGFR-mutated Resectable Non-small Cell Lung Cancer

التفاصيل البيبلوغرافية
العنوان: Progress and Discussion of Perioperative Targeted Therapy in Patients with EGFR-mutated Resectable Non-small Cell Lung Cancer
المؤلفون: Peng SONG, Yong CUI
المصدر: Chinese Journal of Lung Cancer, Vol 27, Iss 5, Pp 383-390 (2024)
بيانات النشر: Chinese Anti-Cancer Association; Chinese Antituberculosis Association, 2024.
سنة النشر: 2024
المجموعة: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
مصطلحات موضوعية: lung neoplasms, perioperative treatment, neoadjuvant treatment, adjuvant treatment, targeted therapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
الوصف: Lung cancer is still the leading cause of cancer death worldwide. Non-small cell lung cancer (NSCLC) is the main pathological type of lung cancer, accounting for about 80%. Approximately 30% of all patients with NSCLC have resectable early and middle stage disease at the time of diagnosis. Recently, the epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) have made a major breakthrough in the adjuvant targeted therapy of EGFR-mutated resectable NSCLC, and are recommended by the guidelines for clinical use. In this review, we summarize the clinical research progress of perioperative adjuvant targeted therapy for EGFR-mutated resectable NSCLC, and discuss the key issues in the clinical researches.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: Chinese
تدمد: 1009-3419
1999-6187
Relation: https://doaj.org/toc/1009-3419; https://doaj.org/toc/1999-6187
DOI: 10.3779/j.issn.1009-3419.2024.106.11
URL الوصول: https://doaj.org/article/60cb89985369406083b5edc922a2c1cc
رقم الأكسشن: edsdoj.60cb89985369406083b5edc922a2c1cc
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:10093419
19996187
DOI:10.3779/j.issn.1009-3419.2024.106.11